Slide 1: First Quarter 2012 Earnings Release
First Quarter 2012 Earnings Release April 24, 2012 Exhibit 99.1
Slide 2: Agenda
Agenda • Q1 2012 Summary • 2012 Segment Performance Fluid & Metering Health & Science Fire & Safety / Diversified • 2012 Guidance Update • Q&A
Slide 3: Replay Information
Replay Information Dial toll–free: 855.859.2056 International: 404.537.3406 Conference ID : #40915423 Log on to: www.idexcorp.com
Slide 4: Cautionary Statement
Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those
Slide 5: IDEX Q1 Financial Performance
IDEX Q1 Financial Performance
Slide 6: Fluid & Metering Q1 Sales Mix
Fluid & Metering Q1 Sales Mix: Organic +8% Acquisition - Fx -1% Total +7% Q1 Summary: • Strong top line growth; North America and Emerging markets • Energy, Chemical, Industrial & Agriculture very strong • Industrial Water solid / Muni Wastewater stabilizing • Excellent operational execution * Op Ma
Slide 7: Health & Science Q1 Sales Mix
Health & Science Q1 Sales Mix: Organic +2% Acquisition +33% Fx - Total +35% Q1 Summary: • Balanced view on end markets • New products and increased content supporting growth • CVI integration on track • Completed PPC deal; M&A pipeline remains full * Op Margin data adjusted for restructuring expense
Slide 8: Fire & Safety / Diversified Q1 Sales Mix
Fire & Safety / Diversified Q1 Sales Mix: Organic +7% Acquisition - Fx -2% Total +5% Q1 Summary: • Strong top line growth; emerging & adjacent markets • Large dispensing replenishment order • Solid backlog, well positioned for remainder of 2012 • Restructuring efforts and leverage driving profitabil
Slide 9: 2012 Guidance: EPS
Q2 2012 • EPS estimate range: $0.70 - $0.72 Mid-to-high single digit organic revenue growth Negative Fx impact of ~2% to sales (at March 31 rates) Positive impact of ~6% from acquisitions FY 2012 • EPS estimate range: $2.80 - $2.85 Organic revenue growth in the mid-single digits Operating margin of